The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question.
COAGULATION/coagulation, COAGULATION/venous thromboembolism prophylaxis, diagnosis, and treatment, PLATELETS/disorders of platelets, PHAGOCYTES/neutrophils, RED CELLS/anemia
clinical: nutritional
iron, cobalamin, folate, anemia, autoimmune neutropenia, iron deficiency, platelets, pre-operative coagulation, thrombophilia
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
pubmed:
29
5
2021
medline:
27
1
2022
entrez:
28
5
2021
Statut:
ppublish
Résumé
Choosing Wisely is a medical stewardship and quality-improvement initiative led by the American Board of Internal Medicine Foundation in collaboration with leading medical societies in the United States. The American Society of Hematology (ASH) has been an active participant in the Choosing Wisely project. In 2019, ASH and the American Society of Pediatric Hematology/Oncology (ASPHO) formed a joint task force to solicit, evaluate, and select items for a pediatric-focused Choosing Wisely list. By using an iterative process and an evidence-based method, the ASH-ASPHO Task Force identified 5 hematologic tests and treatments that health care providers and patients should question because they are not supported by evidence, and/or they involve risks of medical and financial costs with low likelihood of benefit. The ASH-ASPHO Choosing Wisely recommendations are as follows: (1) avoid routine preoperative hemostatic testing in an otherwise healthy child with no previous personal or family history of bleeding, (2) avoid platelet transfusion in asymptomatic children with a platelet count 10 × 10
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e28967Subventions
Organisme : NHLBI NIH HHS
ID : K23 HL150232
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR002547
Pays : United States
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2021 American Society of Hematology. All rights reserved. Pediatric Blood & Cancer published by Wiley Periodicals LLC.
Références
Choosing Wisely®, an initiative of the ABIM Foundation. Promoting conversations between patients and clinicians. 2012. https://www.choosingwisely.org/. Accessed 4 February 2021.
Hicks LK, Bering H, Carson KR, et al. Five hematologic tests and treatments to question. Blood. 2014;124(24):3524-3528. https://doi.org/10.1182/blood-2014-09-599399PubMed
Hicks LK, Bering H, Carson KR, et al. The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Blood. 2013;122(24):3879-3883. https://doi.org/10.1182/blood-2013-07-518423PubMed
Hicks LK, Rajasekhar A, Bering H, et al. Identifying existing Choosing Wisely recommendations of high relevance and importance to hematology. Am J Hematol. 2016;91(8):787-792. https://doi.org/10.1002/ajh.24412PubMed
Jones J, Hunter D. Consensus methods for medical and health services research. BMJ. 1995;311(7001):376-380. https://doi.org/10.1136/bmj.311.7001.376PubMed
McMillan SS, King M, Tully MP. How to use the nominal group and Delphi techniques. Int J Clin Pharm. 2016;38(3):655-662. https://doi.org/10.1007/s11096-016-0257-xPubMed
Alzahrani A, Othman N, Bin-Ali T, et al. Routine preoperative coagulation tests in children undergoing elective surgery or invasive procedures: Are they still necessary? Clin Med Insights Blood Disord. 2019;12:1179545X18821158.
Asaf T, Reuveni H, Yermiahu T, et al. The need for routine pre-operative coagulation screening tests (prothrombin time PT/partial thromboplastin time PTT) for healthy children undergoing elective tonsillectomy and/or adenoidectomy. Int J Pediatr Otorhinolaryngol. 2001;61(3):217-222. https://doi.org/10.1016/S0165-5876(01)00574-2PubMed
Bidlingmaier C, Olivieri M, Hütker S, Dietl S, Kurnik K. Perioperative management of hemostasis in children and adolescents. Blood Cells Mol Dis. 2017;67:91-95. https://doi.org/10.1016/j.bcmd.2017.01.009PubMed
Chee YL, Crawford JC, Watson HG, Greaves M; British Committee for Standards in Haematology. Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. Br J Haematol. 2008;140(5):496-504. https://doi.org/10.1111/j.1365-2141.2007.06968.xPubMed
van Veen JJ, Spahn DR, Makris M. Routine preoperative coagulation tests: an outdated practice? Br J Anaesth. 2011;106(1):1-3. https://doi.org/10.1093/bja/aeq357PubMed
Cooper JD, Smith KJ, Ritchey AK. A cost-effectiveness analysis of coagulation testing prior to tonsillectomy and adenoidectomy in children. Pediatr Blood Cancer. 2010;55(6):1153-1159. https://doi.org/10.1002/pbc.22708PubMed
Bidlingmaier C, Treutwein J, Olivieri M, Kurnik K. Repeated coagulation testing in children. Does it improve the diagnostic value? Hamostaseologie. 2011;31(suppl 1):S51-S56. https://doi.org/10.1055/s-0037-1619750PubMed
Estcourt LJ, Stanworth SJ, Murphy MF. Platelet transfusions for patients with haematological malignancies: who needs them? Br J Haematol. 2011;154(4):425-440. https://doi.org/10.1111/j.1365-2141.2010.08483.xPubMed
National Institute for Health and Care Excellence (NICE). Blood transfusion NICE guideline [NG24]. Published date: 18 November 2015. https://www.nice.org.uk/guidance/ng24. Accessed 4 February 2021.
New HV, Berryman J, Bolton-Maggs PH, et al; British Committee for Standards in Haematology. Guidelines on transfusion for fetuses, neonates and older children. Br J Haematol. 2016;175(5):784-828. https://doi.org/10.1111/bjh.14233PubMed
Schiffer CA, Bohlke K, Delaney M, et al. Platelet transfusion for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2018;36(3):283-299. https://doi.org/10.1200/JCO.2017.76.1734PubMed
Curley A, Stanworth SJ, Willoughby K, et al; PlaNeT2 MATISSE Collaborators. Randomized trial of platelet-transfusion thresholds in neonates. N Engl J Med. 2019;380(3):242-251. https://doi.org/10.1056/NEJMoa1807320PubMed
Fustolo-Gunnink SF, Fijnvandraat K, van Klaveren D, et al; PlaNeT2 and MATISSE collaborators. Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death. Blood. 2019;134(26):2354-2360. https://doi.org/10.1182/blood.2019000899PubMed
Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA; American Society of Hematology. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117(16):4190-4207. https://doi.org/10.1182/blood-2010-08-302984PubMed
van Ommen CH, Heijboer H, Büller HR, Hirasing RA, Heijmans HS, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr. 2001;139(5):676-681. https://doi.org/10.1067/mpd.2001.118192PubMed
Raffini L, Huang YS, Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics. 2009;124(4):1001-1008. https://doi.org/10.1542/peds.2009-0768PubMed
Thrombosis Canada. Central venous catheter-related deep vein thrombosis. 2020. https://thrombosiscanada.ca/clinicalguides/?search=Central/20Venous/0Catheter-Related/20Deep/0Vein/20Thrombosis. Accessed 4 February 2021.
Neshat-Vahid S, Pierce R, Hersey D, Raffini LJ, Faustino EV. Association of thrombophilia and catheter-associated thrombosis in children: a systematic review and meta-analysis. J Thromb Haemost. 2016;14(9):1749-1758. https://doi.org/10.1111/jth.13388PubMed
Monagle P, Cuello CA, Augustine C, et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018;2(22):3292-3316. https://doi.org/10.1182/bloodadvances.2018024786PubMed
National Institute for Health and Care Excellence (NICE). Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. NICE guideline [NG158]. Published date: 26 March 2020. https://www.nice.org.uk/guidance/ng158. Accessed 4 February 2021.
Scottish Intercollegiate Guidelines Network (SIGN) - Healthcare Improvement Scotland. Prevention and management of venous thromboembolism. SIGN 122, October 2014. https://www.sign.ac.uk/our-guidelines/prevention-and-management-of-venous-thromboembolism/. Accessed 4 February 2021.
Baglin T, Gray E, Greaves M, et al; British Committee for Standards in Haematology. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010;149(2):209-220. https://doi.org/10.1111/j.1365-2141.2009.08022.xPubMed
Chalmers E, Ganesen V, Liesner R, et al; British Committee for Standards in Haematology. Guideline on the investigation, management and prevention of venous thrombosis in children. Br J Haematol. 2011;154(2):196-207. https://doi.org/10.1111/j.1365-2141.2010.08543.xPubMed
Avila ML, Amiri N, Stanojevic S, et al. Can thrombophilia predict recurrent catheter-related deep vein thrombosis in children? Blood. 2018;131(24):2712-2719. https://doi.org/10.1182/blood-2017-10-811216PubMed
Hau A, Wegener E, Ignjatovic V, Revel-Vilk S, Monagle P. Family history of venous thromboembolism in the paediatric population: The need for a standardized definition. Thromb Res. 2019;173:91-95. https://doi.org/10.1016/j.thromres.2018.11.016PubMed
Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832-1843. https://doi.org/10.1056/NEJMra1401038PubMed
Powers JM, Buchanan GR. Diagnosis and management of iron deficiency anemia. Hematol Oncol Clin North Am. 2014;28(4):729-745. https://doi.org/10.1016/j.hoc.2014.04.007PubMed
Powers JM, McCavit TL, Buchanan GR. Management of iron deficiency anemia: a survey of pediatric hematology/oncology specialists. Pediatr Blood Cancer. 2015;62(5):842-846. https://doi.org/10.1002/pbc.25433PubMed
Powers JM, Nagel M, Raphael JL, Mahoney DH, Buchanan GR, Thompson DI. Barriers to and facilitators of iron therapy in children with iron deficiency anemia. J Pediatr. 2020;219:202-208. https://doi.org/10.1016/j.jpeds.2019.12.040PubMed
Ning S, Zeller MP. Management of iron deficiency. Hematology Am Soc Hematol Educ Program. 2019;2019:315-322. https://doi.org/10.1182/hematology.2019000034PubMed
Powers JM, Buchanan GR, Adix L, Zhang S, Gao A, McCavit TL. Effect of low-dose ferrous sulfate vs iron polysaccharide complex on hemoglobin concentration in young children with nutritional iron-deficiency anemia: A randomized clinical trial. JAMA. 2017;317(22):2297-2304. https://doi.org/10.1001/jama.2017.6846PubMed
Kaundal R, Bhatia P, Jain A, et al. Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia. Ann Hematol. 2020;99(1):57-63. https://doi.org/10.1007/s00277-019-03871-zPubMed
Moretti D, Goede JS, Zeder C, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015;126(17):1981-1989. https://doi.org/10.1182/blood-2015-05-642223PubMed
Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017;4(11):e524-e533. https://doi.org/10.1016/S2352-3026(17)30182-5PubMed
Stoffel NU, Zeder C, Brittenham GM, Moretti D, Zimmermann MB. Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women. Haematologica. 2020;105(5):1232-1239. https://doi.org/10.3324/haematol.2019.220830PubMed
Boucher AA, Pfeiffer A, Bedel A, Young J, McGann PT. Utilization trends and safety of intravenous iron replacement in pediatric specialty care: A large retrospective cohort study. Pediatr Blood Cancer. 2018;65(6):e26995. https://doi.org/10.1002/pbc.26995PubMed
Crary SE, Hall K, Buchanan GR. Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. Pediatr Blood Cancer. 2011;56(4):615-619. https://doi.org/10.1002/pbc.22930PubMed
Powers JM, Shamoun M, McCavit TL, Adix L, Buchanan GR. Intravenous ferric carboxymaltose in children with iron deficiency anemia who respond poorly to oral iron. J Pediatr. 2017;180:212-216. https://doi.org/10.1016/j.jpeds.2016.09.053PubMed
Sahu S, Hemlata, Verma A. Adverse events related to blood transfusion. Indian J Anaesth. 2014;58(5):543-551. https://doi.org/10.4103/0019-5049.144650PubMed
Toward Optimized Practice (TOP). Iron deficiency anemia (IDA): Clinical Practice Guideline, March 2018. https://top.albertadoctors.org/CPGs/Lists/CPGDocumentList/IDA-CPG.pdf. Accessed 4 February 2021.
British Columbia, BC Guidelines. Iron Deficiency - Diagnosis and Management- Province of British Columbia. https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/iron-deficiency?keyword=Iron&keyword=Deficiency&keyword=/E2/80%93&keyword=Diagnosis&keyword=and&keyword=Management. Accessed 4 February 2021.
Dale DC. How I manage children with neutropenia. Br J Haematol. 2017;178(3):351-363. https://doi.org/10.1111/bjh.14677PubMed
Walkovich K, Boxer LA. How to approach neutropenia in childhood. Pediatr Rev. 2013;34(4):173-184. https://doi.org/10.1542/pir.34-4-173PubMed
Boxer LA, Bolyard AA, Marrero TM, et al. Is there a role for anti-neutrophil antibody testing in predicting spontaneous resolution of neutropenia in young children [abstract]. Blood. 2015;126(23). Abstract 2211. https://doi.org/10.1182/blood.V126.23.2211.2211
Farruggia P, Fioredda F, Puccio G, et al. Idiopathic neutropenia of infancy: Data from the Italian Neutropenia Registry. Am J Hematol. 2019;94(2):216-222. https://doi.org/10.1002/ajh.25353PubMed
Kirk SE, Grimes AB, Shelke S, Despotovic JM, Powers JM. The cost of a “benign” condition: Healthcare utilization and infectious outcomes in young children with primary autoimmune neutropenia. Pediatr Blood Cancer. 2020;67(4):e28146. https://doi.org/10.1002/pbc.28146PubMed
Dale DC, Boxer LA. Guidelines for pediatric management of severe chronic neutropenia. Am J Hematol. 2012;87(2):133. https://doi.org/10.1002/ajh.23107PubMed
Fioredda F, Calvillo M, Bonanomi S, et al; Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica). Congenital and acquired neutropenias consensus guidelines on therapy and follow-up in childhood from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica). Am J Hematol. 2012;87(2):238-243. https://doi.org/10.1002/ajh.22242PubMed